Macrogenics (MGNX) FCF Margin (2012 - 2026)

Macrogenics (MGNX) reported FCF Margin of 173.7% for Q1 2026, up 18575.0% year-over-year from N/an in Q1 2025, and down 267.41% quarter-over-quarter from 103.76% in Q4 2025.

Macrogenics (MGNX) FCF Margin (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of FCF Margin data on file, last reported at 173.7% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 173.7%, up 18575.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 45.6% (down 230.0% YoY), and the FY2025 annual result was 55.49%, down 742.0% from the prior year.
  • FCF Margin declined to 173.7% in Q1 2026 per MGNX's latest filing, from 103.76% in the prior quarter.
  • Over five years, FCF Margin peaked at 103.76% in Q4 2025 and troughed at 1379.39% in Q2 2024.
  • A 5-year average of 236.38% and a median of 173.7% in 2026 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2024 and 2025: FCF Margin plunged 136349 bps in 2024, then soared 116493 bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 35.56% in 2022, then slumped by 852 bps to 267.32% in 2023, then soared by 64 bps to 97.57% in 2024, then soared by 206 bps to 103.76% in 2025, then plunged by 267 bps to 173.7% in 2026.
  • Business Quant data shows MGNX's FCF Margin at 173.7% in Q1 2026, 103.76% in Q4 2025, and 42.03% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Macrogenics 260.14 Mn 193.63 Mn - -173.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 -173.70%
Dec 31, 2025 103.76%
Sep 30, 2025 -42.03%
Jun 30, 2025 -214.47%
Mar 31, 2025 -359.45%
Dec 31, 2024 -97.57%
Sep 30, 2024 53.81%
Jun 30, 2024 -1,379.39%
Mar 31, 2024 -517.38%
Dec 31, 2023 -267.32%
Sep 30, 2023 -348.30%
Jun 30, 2023 -15.90%
Mar 31, 2023 -53.11%
Dec 31, 2022 35.56%
Sep 30, 2022 -17.47%
Jun 30, 2022 -192.92%
Mar 31, 2022 -532.48%
Dec 31, 2021 -393.61%
Sep 30, 2021 -124.52%
Jun 30, 2021 -147.36%